SRRA
Sierra Oncology, Inc. Common Stock
SRRA
SRRA
Delisted
SRRA was delisted on the 30th of June, 2022.
109 hedge funds and large institutions have $1.06B invested in Sierra Oncology, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 71 funds opening new positions, 17 increasing their positions, 16 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
38% less call options, than puts
Call options by funds: $8.79M | Put options by funds: $14.1M
Holders
109
Holding in Top 10
7
Calls
$8.79M
Puts
$14.1M
Top Buyers
| 1 | +$86.9M | |
| 2 | +$49M | |
| 3 | +$39.7M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$27.7M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$27M |
Top Sellers
| 1 | -$80.9M | |
| 2 | -$34.1M | |
| 3 | -$32M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$25.4M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$18.3M |